+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

5-HT2C Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2C Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Platelet Derived Growth Factor Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Platelet Derived Growth Factor Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cholesterol Absorption Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cholesterol Absorption Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bradykinin Receptor B2 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Bradykinin Receptor B2 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bradykinin Receptor B1 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Bradykinin Receptor B1 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Purinergic Receptor (Purinoceptor) Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Purinergic Receptor (Purinoceptor) Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-1 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-2 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-2 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
GABA Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

GABA Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
P2X7 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

P2X7 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Beta-1 Receptors Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-1 Receptors Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
mGlu 2/3 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

mGlu 2/3 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
IL-6 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

IL-6 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
P2Y12 Platelet ADP Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

P2Y12 Platelet ADP Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more